Literature DB >> 27457820

[Limits of the meaningfulness of intensive care medicine : Position paper of the Ethics Section of DIVI].

G Neitzke, H Burchardi, G Duttge, C Hartog, R Erchinger, P Gretenkort, A Michalsen, M Mohr, F Nauck, F Salomon, H Stopfkuchen, N Weiler, U Janssens1.   

Abstract

Mesh：

Year:  2016        PMID： 27457820     DOI： 10.1007/s00063-016-0202-8

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN： 2193-6218            Impact factor:   0.840


× No keyword cloud information.
  2 in total

1.  Current controversies in critical care ethics: not just end of life.

Authors:  Michael A DeVita; Jeffrey Groeger; Robert Truog
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

2.  [Indication: scientific and ethical basis of medical practice].

Authors:  G Neitzke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-12-20       Impact factor: 0.840
  2 in total
  18 in total

Review 1.  [Legal implications of overtreatment].

Authors:  G Duttge
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-02-11       Impact factor: 0.840

2.  [Management of an elderly patient in the emergency room at the end of life : A medical ethics challenge].

Authors:  G Michels; R Nies; S Ortmann; R Pfister; F Salomon
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-08-03       Impact factor: 0.840

Review 3.  [Documentation of decisions to withhold or withdraw life-sustaining therapies : Recommendation of the Ethics Section of the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) in collaboration with the Ethics Section of the German Society for Medical Intensive Care and Emergency Medicine (DGIIN)].

Authors:  G Neitzke; B Böll; H Burchardi; K Dannenberg; G Duttge; R Erchinger; P Gretenkort; C Hartog; K Knochel; M Liebig; A Michalsen; G Michels; M Mohr; F Nauck; P Radke; F Salomon; H Stopfkuchen; U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-09       Impact factor: 0.840

Review 4.  [Therapy escalation for the potential organ donor : Are all intensive care measures also ethically justifiable?]

Authors:  S-O Kuhn; K Hahnenkamp
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-07-26       Impact factor: 0.840

Review 5.  [Choosing wisely recommendations in intensive care medicine].

Authors:  R Riessen; S Kluge; U Janssens; H Kierdorf; K F Bodmann; H-J Busch; S John; M Möckel
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

6.  [Non-beneficial therapy and emotional exhaustion in end-of-life care : Results of a survey among intensive care unit personnel].

Authors:  Christiane S Hartog; F Hoffmann; A Mikolajetz; S Schröder; A Michalsen; K Dey; R Riessen; U Jaschinski; M Weiss; M Ragaller; S Bercker; J Briegel; C Spies; D Schwarzkopf
Journal:  Anaesthesist       Date:  2018-09-12       Impact factor: 1.041

7.  [Difficult decisions in end-of-life situations : An important team task].

Authors:  U Janssens; B Böll; H Burchardi; K Dannenberg; G Duttge; R Erchinger; P Gretenkort; C Hartog; K Knochel; M Liebig; A Michalsen; G Michels; M Mohr; F Nauck; P Radke; F Salomon; H Stopfkuchen; G Neitzke
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-10       Impact factor: 0.840

8.  [Communicating with families in the ICU : Background and practical recommendations].

Authors:  C S Hartog; S Jöbges; O Kumpf; U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-19       Impact factor: 0.840

Review 9.  [Toxicity after chimeric antigen receptor T-cell therapy : Overview and management of early and late onset side effects].

Authors:  Jorge Garcia Borrega; Katrin Heindel; Yasemin Göreci; Clemens Warnke; Oezguer A Onur; Matthias Kochanek; Natalie Schub; Francis Ayuk; Dominic Wichmann; Boris Böll
Journal:  Internist (Berl)       Date:  2021-05-25       Impact factor: 0.743

Review 10.  [The critically ill CAR T-cell patient : Relevant toxicities, their management and challenges in critical care].

Authors:  J Garcia Borrega; K Heindel; M Kochanek; C Warnke; J Stemmler; M von Bergwelt-Baildon; T Liebregts; B Böll
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-02-09       Impact factor: 0.840
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.